GSK will launch an apprenticeship programme later this year to train young people in a range of industry disciplines, including manufacturing, R&D and supply chain management.
Preclinical CRO CiToxLAB has added inhalation testing capacity, citing growing demand from Pharmas and chemicals firms as key driver for the investment.
Filtration and processing tech firm Pall Life Sciences’ biopharmaceutical business made the biggest contribution to its revenues revenues in fiscal Q2.
The new inVentiv Health Communications Europe (iHCE) base – which officially opened last month – will serve as a marketing and support service hub or ‘super agency’ for the contract services firm’s revamped offering.
The joint US FDA and EMA active pharmaceutical ingredient (API) manufacturing facility inspection programme has signed up the World Health Organisation as a member.
in-PharmaTechnologist presents its weekly round-up of the latest changes within the pharmaceutical industry, including news from Akorn, Anthera and Alkermes.
Pierrel Research is close to inking a takeover deal with Swiss R&D firm monoBIOTECH that it says will help shape“the new paradigm of the drug discovery and development process.”
Quintiles’ CEO says CROs need to evolve with Pharmas, take opportunities in emerging markets and help customers demonstrate value to a growing number of stakeholders.
The head of Pfizer's virtual clinical trial has defended the project after its initial failure to recruit patients raised questions about its viability.
Outsourcing-Pharma presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from AMRI, West Pharmaceuticals and Sanofi.
Regulation over combination products must be simplified to get products to market quicker, said Marielle Fournier, director of Voisin Life Sciences Consulting.
Danadams' CEO Yaw Adu Gyamfi will tomorrow meet with the Ghanaian Government urging them to establish a drugs fund which will see more meds manufacturing in the country.
More evidence Russia’s Ministry of Health (MoH) may be getting better at approving trials emerged this week - at least when it comes to international studies.
Celerion and Ricera Biosciences have launched a new joint venture to provide a cost-cutting one-stop-shop solution for companies developing and commercialising biosimilars.
Outsourcing-Pharma presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Cobra, inVentiv and QPharma.
Researchers are calling for alternative excipients for vegetarians who are unwittingly consuming animal fats when physicians prescribe meds containing gelatin.
